Literature DB >> 15496194

Diabetic nephropathy: Linking histology, cell biology, and genetics.

Sharon Adler1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15496194     DOI： 10.1111/j.1523-1755.2004.00988.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  25 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

Review 2.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease.

Authors:  Johan M Lorenzen; Hermann Haller; Thomas Thum
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

3.  Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice.

Authors:  Yong Zhang; Hou-Qin Xiao; Yang Wang; Zhuo-Shun Yang; Long-Jun Dai; Yan-Cheng Xu
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

Review 4.  Update on blood pressure control and renal outcomes in diabetes mellitus.

Authors:  Mark Henry Joven; Robert J Anderson
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

5.  Prevalence and risk factors of diabetic nephropathy in omani type 2 diabetics in Al-dakhiliyah region.

Authors:  Abdulhakeem Hamood Alrawahi; Syed Gauhar A Rizvi; Dawood Al-Riyami; Zaher Al-Anqoodi
Journal:  Oman Med J       Date:  2012-05

6.  Management of Diabetic Nephropathy in the Elderly: Special Considerations.

Authors:  Emaad M Abdel-Rahman; Tarek Alhamad; W Brian Reeves; Alaa S Awad
Journal:  J Nephrol Ther       Date:  2012-10

7.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

8.  Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Authors:  Hang Yuan; Linda Lanting; Zhong-Gao Xu; Shu-Lian Li; Piotr Swiderski; Sumanth Putta; Mahesh Jonnalagadda; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

9.  Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Authors:  Uzma F Mehdi; Beverley Adams-Huet; Philip Raskin; Gloria L Vega; Robert D Toto
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

10.  Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Authors:  Marcus G Pezzolesi; G David Poznik; Josyf C Mychaleckyj; Andrew D Paterson; Michelle T Barati; Jon B Klein; Daniel P K Ng; Grzegorz Placha; Luis H Canani; Jacek Bochenski; Daryl Waggott; Michael L Merchant; Bozena Krolewski; Lucia Mirea; Krzysztof Wanic; Pisut Katavetin; Masahiko Kure; Pawel Wolkow; Jonathon S Dunn; Adam Smiles; William H Walker; Andrew P Boright; Shelley B Bull; Alessandro Doria; John J Rogus; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.